Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T22:58:23.175Z Has data issue: false hasContentIssue false

Neurological Manifestations of West Nile Virus Infection

Published online by Cambridge University Press:  16 February 2016

Jodie M. Burton
Affiliation:
University Health Network, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada Division of Neurology, University of Toronto, Toronto, Ontario, Canada
Ralph Z. Kern
Affiliation:
University Health Network, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada Division of Neurology, University of Toronto, Toronto, Ontario, Canada
William Halliday
Affiliation:
University Health Network, Toronto, Ontario, Canada Division of Neuropathology, University of Toronto, Toronto, Ontario, Canada
David Mikulis
Affiliation:
University Health Network, Toronto, Ontario, Canada Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada Division of Neuroradiology, University of Toronto, Toronto, Ontario, Canada
James Brunton
Affiliation:
University Health Network, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada Division of Infectious Diseases, University of Toronto, Toronto, Ontario, Canada
Margaret Fearon
Affiliation:
Laboratories Branch, Ministry of Health and Long Term Care, University of Toronto, Toronto, Ontario, Canada
Caitlin Pepperell
Affiliation:
University Health Network, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada Division of Infectious Diseases, University of Toronto, Toronto, Ontario, Canada
Cheryl Jaigobin*
Affiliation:
University Health Network, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada Division of Neurology, University of Toronto, Toronto, Ontario, Canada
*
Toronto General Hospital, University Health Network, Eaton North 11-215, 200 Elizabeth Street, Toronto, ON M5G 2C4 Canada.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Over the past four years, West Nile virus (WNV) has become a significant health issue in North America. In 2002, WNV infection made its first appearance in the human population in Canada.

Methods:

Patients who presented to the University Health Network and Mount Sinai Hospital in Toronto with neurological disease attributed to WNV infection were identified and followed by the neurology service. Clinical features and results of laboratory, electrodiagnostic, radiological and pathological studies are presented.

Results:

In August and September 2002, 26 patients were admitted with WNV infection; 14 presented with neurological illness. Encephalitis was the most common presentation (11 patients). Eleven patients developed neuromuscular disease; two at presentation and nine after encephalitis. While the majority had a motor process that localized to the anterior horn cell and/or motor neuron, two patients had evidence of a demyelinating neuropathy and one a sensorimotor axonal neuropathy. Less common manifestations included rhombencephalitis, ataxia, myelopathy and parkinsonism. Death occurred in four patients; two > 75 years of age, and two who were immunocompromised.

Conclusions:

The most common neurological manifestation of WNV infection was encephalitis with subsequent neuromuscular involvement. The diversity of clinical and pathological findings, however, suggests widespread involvement of the central and peripheral nervous system. A poorer prognosis for neurological recovery and overall survival was seen in older and immunocompromised patients.

Type
Original Article
Copyright
Copyright © The Canadian Journal of Neurological 2004

References

1.Turell, MJ, Sardelis, MR, Dohm, DJ, O’Guinn, ML. Potential North American vectors of West Nile virus. Ann NY Acad Sci 2001; 951: 317324.CrossRefGoogle ScholarPubMed
2.Nash, D, Mostashari, F, Fine, A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344: 18071814.CrossRefGoogle ScholarPubMed
3.Campbell, GL, Marfin, AA, Lanciotti, RS, Gubler, DJ. West Nile Virus. Lancet Infect Dis 2002; 2: 519529.CrossRefGoogle ScholarPubMed
4.Mostashari, F, Bunning, ML, Kitsutani, PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261264.CrossRefGoogle ScholarPubMed
5.Peterson, LR, Martin, AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137: 173179.CrossRefGoogle Scholar
6.Chowers, MY, Lang, R, Nassar, F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infect Dis 2001; 7: 675678.Google ScholarPubMed
7.Halton Region Public Health. WNV surveillance data in Halton 2002. 5-13-0003. Ref Type: Internet Communication.Google Scholar
8.Clarke, D, Casals, J. Techniques for hemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7:561573.CrossRefGoogle ScholarPubMed
9.Martin, DA, Muth, DA, Brown, T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000; 38: 18231826.CrossRefGoogle ScholarPubMed
10.Centers for Disease Control and Prevention. Epidemic/epizootic West Nile virus in the United States: revised guidelines for surveillance, prevention, and control. Available at: http://www.cdc.gov/ncidod/dvbid/westnile/resources/wnv-guidelines-apr-2001.pdf. Accessed May 5, 2003.Google Scholar
11.Pepperell, C, Rau, N, Krajden, S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. Can Med Assoc J 2003; 168: 13991405.Google ScholarPubMed
12.Xiao, S, Guzman, H, Zhang, H, Travassos da Rosa, APA, Tesh, RB. West Nile virus infection in the golden hamster (Mesocricetus auratua): a model for West Nile encephalitis. Emerg Infect Dis 2001; 7: 714721.CrossRefGoogle Scholar
13.Manulidis, EE. Neuropathology of experimental West Nile virus infection in monkeys. J Neuropath Exp Neurol 1956;15: 448460.CrossRefGoogle Scholar
14.Steele, KE, Linn, MJ, Schoepp, RJ, et al. Pathology of fatal West Nile Virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol 2000; 37: 208224.CrossRefGoogle ScholarPubMed
15.Klein, C, Kimiagar, I, Pollak, L, et al. Neurological features of West Nile virus infection during the 2000 outbreak in a regional hospital in Israel. J Neurol Sci 2002; 200: 6366.CrossRefGoogle Scholar
16.Sejvar, JJ, Haddad, M, Tierney, BCet al. Neurological manifestations and outcome ofWest Nile virus infection. JAMA 2003; 290: 511515.CrossRefGoogle Scholar
17.Jeha, LE, Sila, CA, Lederman, RJ, et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003; 61: 5559.CrossRefGoogle ScholarPubMed
18.Li, J, Loeb, JA, Shy, ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003; 53: 703710.CrossRefGoogle ScholarPubMed
19.Iwamoto, M, Jernigan, DB, Guasch, A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 21962203.CrossRefGoogle ScholarPubMed
20. Pealer, LN, Marfin, AA, Petersen, LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 12361245.CrossRefGoogle ScholarPubMed
21.Hong, DS, Jacobson, KL, Raad, II, et al. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis 2003; 37: 10441049.CrossRefGoogle ScholarPubMed
22.Petersen, LR, Marfin, AA, Gubler, DJ. West Nile virus. JAMA 2003; 290: 524528.CrossRefGoogle ScholarPubMed